Literature DB >> 1424274

Immune response to hepatitis B virus surface antigen peptides during HBV infection.

A Mishra1, H Durgapal, V Manivel, S K Acharya, K V Rao, S K Panda.   

Abstract

Antibody responses of patients with acute (n = 73), fulminant (n = 30) and chronic (n = 51) hepatitis B virus (HBV) infection as well as recovered individuals (n = 7) were studied against three synthetic peptides, Pre-S1 amino acids (aa. 12-32), Pre-S2 amino acids (aa. 120-145), and S amino acids (aa. 124-147) of the envelope region (HBsAg). T cell blastogenic response was investigated in a proportion of the patients (27 acute, nine fulminant, 13 chronic hepatitis and seven recovered individuals) along with seven HBV vaccinated and three normal individuals. The presence of T cell response against S peptide was observed in all the cases (9/9, 100%) during early acute hepatitis. This was suppressed during late stages (8/18, 44%) followed by partial reversal during recovery (5/7, 71%). T cell response and antibodies to Pre-S1 and Pre-S2 peptides were present only in one-third of the patients throughout these periods. The T cell blastogenic response as well as antibody reactivity against these peptides were absent and minimal in chronic hepatitis. Immune response against envelope protein appears to play a major role in acute hepatic injury due to HBV infection and help in virus clearance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424274      PMCID: PMC1554618     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.

Authors:  D R Milich; J L Hughes; A McLachlan; G B Thornton; A Moriarty
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Fulminant hepatic failure. Presumable contribution to halothane.

Authors:  C Trey; L Lipworth; T C Chalmers; C S Davidson; L S Gottlieb; H Popper; S J Saunders
Journal:  N Engl J Med       Date:  1968-10-10       Impact factor: 91.245

Review 4.  The role of CD4 and CD8 T cells in viral infections.

Authors:  U H Koszinowski; M J Reddehase; S Jonjic
Journal:  Curr Opin Immunol       Date:  1991-08       Impact factor: 7.486

5.  Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.

Authors:  T Moriyama; S Guilhot; K Klopchin; B Moss; C A Pinkert; R D Palmiter; R L Brinster; O Kanagawa; F V Chisari
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

6.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

7.  Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.

Authors:  S Iwarson; E Tabor; H C Thomas; A Goodall; J Waters; P Snoy; J W Shih; R J Gerety
Journal:  J Med Virol       Date:  1985-05       Impact factor: 2.327

8.  Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

Authors:  C Ferrari; A Penna; P Sansoni; T Giuberti; T M Neri; F V Chisari; F Fiaccadori
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

9.  Mechanisms of liver cell damage in acute hepatitis B.

Authors:  B J Mohite; S Rath; V Bal; S A Kamat; S N Marathe; A J Zuckerman; R S Kamat
Journal:  J Med Virol       Date:  1987-07       Impact factor: 2.327

10.  Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease.

Authors:  J Aldershvile; O Dietrichson; F Hardt; J O Nielsen; P Skinhöj
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

View more
  2 in total

1.  Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.

Authors:  K Kurose; S M Akbar; K Yamamoto; M Onji
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

2.  Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.

Authors:  A Mishra; K V Rao; H Durgapal; V Manivel; S K Panda
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.